277 related articles for article (PubMed ID: 32838558)
1. Behavioral and social science research to support development of educational materials for clinical trials of broadly neutralizing antibodies for HIV treatment and prevention.
Valente PK; Wu Y; Cohen YZ; Caskey M; Meyers K
Clin Trials; 2021 Feb; 18(1):17-27. PubMed ID: 32838558
[TBL] [Abstract][Full Text] [Related]
2. Cultural feasibility studies in preparation for clinical trials to reduce maternal-infant HIV transmission in Haiti.
Coreil J; Losikoff P; Pincu R; Mayard G; Ruff AJ; Hausler HP; Desormeau J; Davis H; Boulos R; Halsey NA
AIDS Educ Prev; 1998 Feb; 10(1):46-62. PubMed ID: 9505098
[TBL] [Abstract][Full Text] [Related]
3. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
4. Improving ethical and participatory practice for marginalized populations in biomedical HIV prevention trials: lessons from Thailand.
Allman D; Ditmore MH; Kaplan K
PLoS One; 2014; 9(6):e100058. PubMed ID: 24949864
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. The psychology of "cure" - unique challenges to consent processes in HIV cure research in South Africa.
Moodley K; Staunton C; Rossouw T; de Roubaix M; Duby Z; Skinner D
BMC Med Ethics; 2019 Jan; 20(1):9. PubMed ID: 30678664
[TBL] [Abstract][Full Text] [Related]
7. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody.
Edupuganti S; Mgodi N; Karuna ST; Andrew P; Rudnicki E; Kochar N; deCamp A; De La Grecca R; Anderson M; Karg C; Tindale I; Greene E; Broder GB; Lucas J; Hural J; Gallardo-Cartagena JA; Gonzales P; Frank I; Sobieszczyk M; Gomez Lorenzo MM; Burns D; Anderson PL; Miner MD; Ledgerwood J; Mascola JR; Gilbert PB; Cohen MS; Corey L;
J Acquir Immune Defic Syndr; 2021 May; 87(1):671-679. PubMed ID: 33587505
[TBL] [Abstract][Full Text] [Related]
9. Participants' characteristics and motivations to screen for HIV vaccine and monoclonal antibody trials in KwaZulu-Natal, South Africa.
Hanass-Hancock J; Carpenter B; Reddy T; Nzuza A; Gaffoor Z; Goga A; Andrasik M
Trials; 2021 Dec; 22(1):897. PubMed ID: 34895272
[TBL] [Abstract][Full Text] [Related]
10. Broadening community engagement in clinical research: Designing and assessing a pilot crowdsourcing project to obtain community feedback on an HIV clinical trial.
Day S; Mathews A; Blumberg M; Vu T; Rennie S; Tucker JD
Clin Trials; 2020 Jun; 17(3):306-313. PubMed ID: 32009466
[TBL] [Abstract][Full Text] [Related]
11. Examining study participants' decision-making and ethics-related experiences in a dietary community randomized controlled trial in Malawi.
Matandika L; Millar K; Umar E; Joy E; Chiutsi-Phiri G; Mfutso-Bengo J
BMC Med Ethics; 2021 Dec; 22(1):160. PubMed ID: 34861869
[TBL] [Abstract][Full Text] [Related]
12. Multiple roles for HIV broadly neutralizing antibodies.
Haynes BF; Burton DR; Mascola JR
Sci Transl Med; 2019 Oct; 11(516):. PubMed ID: 31666399
[TBL] [Abstract][Full Text] [Related]
13. 'Well, It's the Risk of the Unknown… Right?': A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United States.
Dubé K; Taylor J; Sylla L; Evans D; Dee L; Burton A; Willenberg L; Rennie S; Skinner A; Tucker JD; Weiner BJ; Greene SB
PLoS One; 2017; 12(1):e0170112. PubMed ID: 28122027
[TBL] [Abstract][Full Text] [Related]
14. Broadly Neutralizing Antibodies for HIV Prevention.
Karuna ST; Corey L
Annu Rev Med; 2020 Jan; 71():329-346. PubMed ID: 31986089
[TBL] [Abstract][Full Text] [Related]
15. Audio-visual presentation of information for informed consent for participation in clinical trials.
Ryan RE; Prictor MJ; McLaughlin KJ; Hill SJ
Cochrane Database Syst Rev; 2008 Jan; (1):CD003717. PubMed ID: 18254029
[TBL] [Abstract][Full Text] [Related]
16. Indirect Benefits in HIV Cure Clinical Research: A Qualitative Analysis.
Gilbertson A; Kelly EP; Rennie S; Henderson G; Kuruc J; Tucker JD
AIDS Res Hum Retroviruses; 2019 Jan; 35(1):100-107. PubMed ID: 30009625
[TBL] [Abstract][Full Text] [Related]
17. Crowdsourcing contests to facilitate community engagement in HIV cure research: a qualitative evaluation of facilitators and barriers of participation.
Zhao Y; Day S; Yang NS; Bao H; Li L; Mathews A; Tucker JD
BMC Public Health; 2020 Jan; 20(1):67. PubMed ID: 31941478
[TBL] [Abstract][Full Text] [Related]
18. Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States.
Bilger A; Plenn E; Barg FK; Rendle KA; Carter WB; Lamour-Harrington A; Jones N; Peterson B; Sauceda JA; Tebas P; Mounzer K; Metzger D; Montaner LJ; Dubé K
HIV Res Clin Pract; 2023 Oct; 24(1):2267825. PubMed ID: 37837376
[TBL] [Abstract][Full Text] [Related]
19. Understanding the Acceptability of Broadly Neutralizing Antibodies for HIV Prevention Among At-Risk Populations and Feasibility Considerations for Product Introduction in India: Protocol for a Qualitative Study.
Mukherjee J; Rawat S; Ul Hadi S; Aggarwal P; Chakrapani V; Rath P; Manchi P; Aylur S; Malhotra S; Keane M; Gangaramany A
JMIR Res Protoc; 2024 Feb; 13():e47700. PubMed ID: 38324364
[TBL] [Abstract][Full Text] [Related]
20. Advancing community stakeholder engagement in biomedical HIV prevention trials: principles, practices and evidence.
Newman PA; Rubincam C
Expert Rev Vaccines; 2014 Dec; 13(12):1553-62. PubMed ID: 25174764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
